• 20 Jan 2026
• Admin
• News Article

Smartee’s 2025 Annual Report: From Rapid Growth to Global Maturity

2025 marked a turning point for Smartee Denti-Technology. The company moved from fast expansion to sustainable global scale, driven by clinical validation, manufacturing depth, and professional education.

A Major Clinical Milestone:100,000+ Mandibular Repositioning Cases

Smartee crossed a key threshold in 2025. Its GS mandibular repositioning technology was applied in more than 100,000 clinical cases worldwide.

This milestone validates clear aligners as a serious alternative to:

• Tooth extraction
• Orthognathic surgery
• Traditional mechanical correction

The technology is now widely used to treat:

• Class II malocclusion
• Class III malocclusion
• Severe misalignment cases

Growing Academic Recognition

Clinical adoption was matched by academic momentum.

The Journal of Aligner Orthodontics (JAO) published two peer-reviewed articles on Smartee protocols in 2025:

• Issue 2, 2025
  • Authored by Dr. Xingxing Wang
  • Focused on Class II treatment using sagittal-guided double-block clear splints (S8-SGTB)
• Issue 4, 2025
  • Led by Professor Gang Shen and team
  • Detailed clinical mechanisms and outcomes in adult three-depth malocclusion

This accelerated acceptance of mandibular repositioning within aligner-based orthodontics.

Manufacturing Scale and the Straumann Partnership

To meet global demand, Smartee opened a 100,000 m² smart manufacturing facility in 2025.

Key highlights:

• Fully automated production lines
• Modular expansion capability
• Support for in-house and partner brands

That capacity was validated through a strategic partnership with Straumann Group.

Under the agreement:

• Smartee will manufacture ClearCorrect aligners
• Coverage includes select EMEA and APAC markets
• Production ensures consistency at scale

This positions Smartee as both a technology innovator and a global manufacturing partner.

R&D Expansion: Night Devices and AI Planning

Smartee Night Splints (Launched October 1)

Smartee entered the sleep apnea device market in Q4 2025. The Night Splints target mild to moderate OSAHS and feature:

• Patented dual-splint digital locking system
• Ultra-thin 1 mm profile
• Improved patient comfort

Clinical impact:

• Up to 23% oropharyngeal airway expansion

Two variants are available:

• SA: Standalone sleep apnea therapy
• SA Plus: Combined airway management and orthodontic movement

Smartee Live 3D (Launched October 30)

Smartee also launched Live 3D, an AI-powered treatment planning system.

What changed:

• Initial 3D treatment plans generated in 30 minutes
• End-to-end planning completed in under one hour
• Deep learning improves accuracy and workflow speed

Combined with LiveUpdate, this significantly reduces case turnaround time.

Strengthening Europe-Focused Clinical Support

Smartee expanded its European presence in 2025.

Key developments:

• UK-dedicated subsidiary
• European Orthodontic Clinical Support Centre in Stoke-on-Trent

The center delivers:

• Localized treatment planning
• Region-specific biomechanical standards
• Faster clinical support for European partners

Training, Awareness, and Global Knowledge Exchange

Education remained a core pillar. In 2025, Smartee:

• Participated in 27 international conferences, including IDS Cologne and SEDO Spain
• Hosted large-scale professional training worldwide

Training Highlights

Global World Tour

• 17 cities, including Paris, Tokyo, and Rome
• 11,000+ professionals trained on GS technology

China-Focused Programs

• 14,330 participants nationwide
• Expanded access beyond Tier-1 cities
• Supported emerging regional markets

Early Pediatric Orthodontics

• Summits held in Singapore, Melbourne, and Disneyland® Paris
• International myofunctional therapy symposium in Shanghai

ESG Progress in 2025

Smartee advanced its sustainability agenda.

Key actions:

• Solar energy projects reducing 209 tonnes of CO₂ annually
• Digital governance tools to support employee well-being

The Big Picture

Smartee’s 2025 story is not just about growth.

It’s about:

• Clinical credibility at scale
• Manufacturing trust from global leaders
• Technology that shortens workflows
• Training that builds ecosystems, not just users

The company entered 2026 positioned as a mature global orthodontic platform, not just an aligner manufacturer.

About Smartee Denti-Technology

Founded in 2004, Smartee is a global leader in digital orthodontics and clear aligner manufacturing. Key facts:

• 4 R&D centers
• 4 production facilities in China and Spain
• 99,000+ physician partners
• Presence in 57 countries

Core product lines include:

• Smartee GS (mandibular repositioning)
• Smartee GE

• Smartee Kinder / Teen series